Lafayette Investments’s Pfizer PFE Stock Holding History

Lafayette Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$415K	Sell	17,215 -2,184	-11%	-$57.1K	0.08%	117
2026 Q1	$545K	Sell	19,399 -788	-4%	-$21K	0.11%	101
2025 Q4	$503K	Sell	20,187 -165	-0.8%	-$4.16K	0.1%	100
2025 Q3	$519K	Sell	20,352 -151	-0.7%	-$3.73K	0.1%	95
2025 Q2	$497K	Hold	20,503	–	–	0.1%	95
2025 Q1	$520K	Sell	20,503 -255	-1%	-$6.67K	0.11%	90
2024 Q4	$551K	Buy	20,758 +559	+3%	+$15.2K	0.12%	82
2024 Q3	$585K	Sell	20,199 -100	-0.5%	-$2.92K	0.12%	81
2024 Q2	$568K	Buy	20,299 +2,751	+16%	+$75.7K	0.13%	81
2024 Q1	$487K	Hold	17,548	–	–	0.11%	85
2023 Q4	$505K	Buy	17,548 +78	+0.4%	+$2.36K	0.13%	81
2023 Q3	$579K	Buy	17,470 +368	+2%	+$13K	0.16%	74
2023 Q2	$627K	Hold	17,102	–	–	0.16%	72
2023 Q1	$698K	Hold	17,102	–	–	0.19%	69
2022 Q4	$876K	Hold	17,102	–	–	0.25%	65
2022 Q3	$748K	Hold	17,102	–	–	0.23%	67
2022 Q2	$897K	Hold	17,102	–	–	0.26%	65
2022 Q1	$885K	Hold	17,102	–	–	0.22%	66
2021 Q4	$1.01M	Sell	17,102 -120	-0.7%	-$5.95K	0.25%	65
2021 Q3	$741K	Hold	17,222	–	–	0.2%	67
2021 Q2	$674K	Buy	17,222 +353	+2%	+$13.7K	0.18%	69
2021 Q1	$611K	Hold	16,869	–	–	0.2%	62
2020 Q4	$621K	Sell	16,869 -911	-5%	-$33.4K	0.21%	62
2020 Q3	$619K	Buy	17,780 +427	+2%	+$15K	0.24%	62
2020 Q2	$538K	Hold	17,353	–	–	0.22%	62
2020 Q1	$537K	Sell	17,353 -137	-0.8%	-$4.67K	0.26%	56
2019 Q4	$650K	Hold	17,490	–	–	0.23%	53
2019 Q3	$596K	Sell	17,490 -148	-0.8%	-$5.38K	0.22%	54
2019 Q2	$725K	Hold	17,638	–	–	0.26%	52
2019 Q1	$711K	Sell	17,638 -577	-3%	-$23.1K	0.26%	51
2018 Q4	$754K	Buy	18,215 +515	+3%	+$21.4K	0.3%	51
2018 Q3	$740K	Buy	17,700 +147	+0.8%	+$5.66K	0.26%	53
2018 Q2	$604K	Hold	17,553	–	–	0.22%	51
2018 Q1	$591K	Sell	17,553 -1,631	-9%	-$56.1K	0.22%	49
2017 Q4	$659K	Sell	19,184 -1,428	-7%	-$48.7K	0.24%	46
2017 Q3	$698K	Sell	20,612 -234	-1%	-$7.52K	0.26%	46
2017 Q2	$664K	Hold	20,846	–	–	0.25%	44
2017 Q1	$677K	Hold	20,846	–	–	0.25%	44
2016 Q4	$642K	Hold	20,846	–	–	0.25%	44
2016 Q3	$670K	Sell	20,846 -95	-0.5%	-$3.18K	0.27%	41
2016 Q2	$700K	Hold	20,941	–	–	0.28%	40
2016 Q1	$589K	Sell	20,941 -679	-3%	-$19.4K	0.24%	42
2015 Q4	$662K	Sell	21,620 -168	-0.8%	-$5.29K	0.28%	43
2015 Q3	$649K	Hold	21,788	–	–	0.28%	42
2015 Q2	$693K	Hold	21,788	–	–	0.29%	40
2015 Q1	$719K	Sell	21,788 -1,668	-7%	-$53K	0.3%	40
2014 Q4	$693K	Hold	23,456	–	–	0.29%	41
2014 Q3	$658K	Sell	23,456 -184	-0.8%	-$5.16K	0.3%	40
2014 Q2	$666K	Hold	23,640	–	–	0.29%	40
2014 Q1	$720K	Hold	23,640	–	–	0.33%	40
2013 Q4	$687K	Sell	23,640 -4,153	-15%	-$121K	0.32%	39
2013 Q3	$757K	Hold	27,793	–	–	0.37%	41
2013 Q2	$739K	Buy	+27,793	New	+$768K	0.35%	42

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Lafayette Investments's PFE Position: Q2 2026 in Review

Lafayette Investments reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $57.1K and leaving 17,215 shares worth $415K. The position accounts for 0.08% of the portfolio, ranked #117.

Lafayette Investments first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.01M in Q4 2021. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Lafayette Investments held 17,215 shares of Pfizer worth $415K as of Q2 2026.
Lafayette Investments sold 2,184 Pfizer shares in Q2 2026, an estimated $57.1K.
Pfizer made up 0.08% of Lafayette Investments's portfolio in Q2 2026, its #117 holding.
Lafayette Investments first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Lafayette Investments's Pfizer position peaked at $1.01M in Q4 2021.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lafayette Investments's 13F filing for Q2 2026, filed 11 Aug 2026.